The pharma story is similar both on the generic front as well as on local businesss so we like IPCA laboratories ays Gautam Chhaochharia, UBS India
first published: Jun 10, 2013 03:59 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty extends gain to the second straight day but sees another weekly loss | Closing Bell

Live: Can Nifty extend gains and reclaim 26,000? | Opening Bell
FSS Simply Payments 2025 | AI in Payments: Building a Governance-First Future.

Live: Nifty reclaims 25,900, snaps 3-day losing streak; rupee falls to fresh low | Closing Bell
You are already a Moneycontrol Pro user.


